The effect and associated mechanism of action of phosphodiesterase 4 (PDE4) inhibitor on CD4+ lymphocyte proliferation - Kim - 2021 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library
PDE4 inhibitors in COPD—a more selective approach to treatment - ScienceDirect
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial - The Lancet
DALIRESP® (roflumilast) Mechanism of Action | For HCPs
New Therapeutic Options for COPD - ppt video online download
The Korean Journal of Internal Medicine
Roflumilast (Daliresp) for Chronic Obstructive Pulmonary Disease - STEPS - American Family Physician
New Therapies for Asthma & COPD - ppt video online download
Pharmacological mechanism of roflumilast in the treatment of asthma&nd | DDDT
Frontiers | Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases | Pharmacology
Daliresp (roflumilast): Uses, Dosage, Side Effects, Interactions, Warning
Frontiers | Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases | Pharmacology
New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19. - Abstract - Europe PMC
New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19 - ScienceDirect
Mechanism of action of phosphodiesterase 4 inhibitors (PDEIs). PDE4Is... | Download Scientific Diagram
Romilast | Roflumilast | The perfect Solution for COPD | New Product Launching | Mode of action - YouTube
PDE4 inhibitors in COPD—a more selective approach to treatment - Respiratory Medicine
Emerging anti-inflammatory strategies for COPD | European Respiratory Society
Pharmacological mechanism of roflumilast in ACO. Abbreviations: ACO,... | Download Scientific Diagram